Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 55

    1.

    Key articles and guidelines in the treatment of venous thromboembolism.

    Dobesh PP, Wittkowsky AK, Stacy Z, Dager WE, Trujillo TC, Gulseth MP, Nutescu E, Vondracek T.

    Pharmacotherapy. 2009 Nov;29(11):1385.PMID: 19857153 [PubMed - in process]Related articles

    2.

    Key articles and guidelines relative to intensive care unit pharmacotherapy: 2009 update.

    Erstad BL, Brophy GM, Martin SJ, Haas CE, Devlin JW, Welage LS, Dager WE.

    Pharmacotherapy. 2009 Oct;29(10):1228-69.PMID: 19792995 [PubMed - in process]Related articles

    3.

    Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings.

    Nutescu EA, Spinler SA, Wittkowsky A, Dager WE.

    Ann Pharmacother. 2009 Jun;43(6):1064-83. Epub 2009 May 19. Review.PMID: 19458109 [PubMed - indexed for MEDLINE]Related articles

    4.

    Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.

    Heintz BH, Matzke GR, Dager WE.

    Pharmacotherapy. 2009 May;29(5):562-77. Review.PMID: 19397464 [PubMed - indexed for MEDLINE]Related articles

    5.

    Key articles and guidelines for the prevention of venous thromboembolism.

    Dobesh PP, Wittkowsky AK, Stacy Z, Dager WE, Haines ST, Lopez LM, Nutescu E, Phillips KW, Trujillo TC, Vondracek T.

    Pharmacotherapy. 2009 Apr;29(4):410-58.PMID: 19323620 [PubMed - indexed for MEDLINE]Related articles

    6.

    Pharmacogenomics of warfarin: uncovering a piece of the warfarin mystery.

    Gulseth MP, Grice GR, Dager WE.

    Am J Health Syst Pharm. 2009 Jan 15;66(2):123-33. Review.PMID: 19139476 [PubMed - indexed for MEDLINE]Related articles

    7.

    Dosing nomograms: silos on a slope.

    Dager WE.

    Ann Pharmacother. 2009 Jan;43(1):114-7. Epub 2009 Jan 6.PMID: 19126822 [PubMed - in process]Related articles

    8.

    Considerations for drug dosing post coronary artery bypass graft surgery.

    Dager WE.

    Ann Pharmacother. 2008 Mar;42(3):421-4. Epub 2008 Feb 26.PMID: 18303139 [PubMed - indexed for MEDLINE]Related articles

    9.

    Key articles and guidelines in the management of acute coronary syndromes and in percutaneous coronary intervention: 2007 update.

    Dobesh PP, Brouse SD, Dager WE, Spinler SA, Stacy Z, Wiggins BS.

    Pharmacotherapy. 2007 Dec;27(12):1722-58.PMID: 18041892 [PubMed - indexed for MEDLINE]Related articles

    10.

    Improving anticoagulation management in patients with atrial fibrillation.

    Dager WE.

    Am J Health Syst Pharm. 2007 Nov 1;64(21):2279-80. No abstract available. PMID: 17959581 [PubMed - indexed for MEDLINE]Related articles

    11.

    Implementing anticoagulation management by pharmacists in the inpatient setting.

    Dager WE, Gulseth MP.

    Am J Health Syst Pharm. 2007 May 15;64(10):1071-9.PMID: 17494907 [PubMed - indexed for MEDLINE]Related articles

    12.

    Recent FDA warning of the concomitant use of aspirin and ibuprofen and the effects on platelet aggregation.

    Ellison J, Dager W.

    Prev Cardiol. 2007 Spring;10(2):61-3. No abstract available. PMID: 17392619 [PubMed - indexed for MEDLINE]Related articles

    13.

    Heparin-induced thrombocytopenia: treatment options and special considerations.

    Dager WE, Dougherty JA, Nguyen PH, Militello MA, Smythe MA.

    Pharmacotherapy. 2007 Apr;27(4):564-87. Review.PMID: 17381384 [PubMed - indexed for MEDLINE]Related articles

    14.

    Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patients.

    Chan A, Iannucci A, Dager WE.

    Ann Pharmacother. 2007 Apr;41(4):635-41. Epub 2007 Mar 13. Review.PMID: 17355999 [PubMed - indexed for MEDLINE]Related articles

    15.

    Usefulness of optical density values from heparin-platelet factor 4 antibody testing and probability scoring models to diagnose heparin-induced thrombocytopenia.

    Janatpour KA, Gosselin RC, Dager WE, Lee A, Owings JT, Zhou J, Wun T.

    Am J Clin Pathol. 2007 Mar;127(3):429-33.PMID: 17276943 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Pharmacotherapy considerations in advanced cardiac life support.

    Dager WE, Sanoski CA, Wiggins BS, Tisdale JE.

    Pharmacotherapy. 2006 Dec;26(12):1703-29. Review.PMID: 17125434 [PubMed - indexed for MEDLINE]Related articles

    17.

    Racial and gender differences in the incidence of recurrent venous thromboembolism.

    White RH, Dager WE, Zhou H, Murin S.

    Thromb Haemost. 2006 Sep;96(3):267-73.PMID: 16953266 [PubMed - indexed for MEDLINE]Related articles

    18.

    Critical pathways: the role of pharmacy today and tomorrow.

    Dobesh PP, Bosso J, Wortman S, Dager WE, Karpiuk EL, Ma Q, Zarowitz BJ; ACCP Task Force on Critical Pathways.

    Pharmacotherapy. 2006 Sep;26(9):1358-68. Review. No abstract available. PMID: 16945060 [PubMed - indexed for MEDLINE]Related articles

    19.

    Choosing the appropriate antithrombotic agent for the prevention and treatment of VTE: a case-based approach.

    Nutescu EA, Wittkowsky AK, Dobesh PP, Hawkins DW, Dager WE.

    Ann Pharmacother. 2006 Sep;40(9):1558-71. Epub 2006 Aug 15. Review.PMID: 16912250 [PubMed - indexed for MEDLINE]Related articles

    20.

    Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin.

    Dager WE, King JH, Regalia RC, Williamson D, Gosselin RC, White RH, Tharratt RS, Albertson TE.

    Pharmacotherapy. 2006 Aug;26(8):1091-8.PMID: 16863486 [PubMed - indexed for MEDLINE]Related articles

    21.

    Acute generalized exanthematous pustulosis as a delayed dermatotoxic reaction to IV-administered nonionic contrast media.

    Peterson A, Katzberg RW, Fung MA, Wootton-Gorges SL, Dager W.

    AJR Am J Roentgenol. 2006 Aug;187(2):W198-201.PMID: 16861512 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Achieving optimal antiarrhythmic therapy in advanced cardiac life support.

    Dager WE.

    Crit Care Med. 2006 Jun;34(6):1825-6. No abstract available. PMID: 16714985 [PubMed - indexed for MEDLINE]Related articles

    23.

    Aminoglycoside elimination in extended duration hemodialysis.

    Dager WE.

    Ann Pharmacother. 2006 Apr;40(4):783-4. Epub 2006 Mar 28. No abstract available. PMID: 16569808 [PubMed - indexed for MEDLINE]Related articles

    24.

    Filtering out important considerations for developing drug-dosing regimens in extended daily dialysis.

    Dager WE.

    Crit Care Med. 2006 Jan;34(1):240-1. No abstract available. PMID: 16374185 [PubMed - indexed for MEDLINE]Related articles

    25.

    Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.

    Dager WE, King JH.

    Ann Pharmacother. 2006 Jan;40(1):9-14. Epub 2005 Dec 6.PMID: 16332944 [PubMed - indexed for MEDLINE]Related articles

    26.

    Comment: extensive prolongation of aPTT with argatroban in an elderly patient with improving renal function, normal hepatic enzymes, and metastatic lung cancer.

    Spinler SA, Dager W.

    Ann Pharmacother. 2005 Nov;39(11):1955-6; author reply 1956-7. Epub 2005 Oct 11. No abstract available. PMID: 16219889 [PubMed - indexed for MEDLINE]Related articles

    27.

    Uncertain times for oral anticoagulation therapy.

    Nutescu EA, Wittkowsky AK, Dager WE.

    Am J Health Syst Pharm. 2005 Jul 15;62(14):1449. No abstract available. PMID: 15998924 [PubMed - indexed for MEDLINE]Related articles

    28.

    Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis.

    Dager WE, King JH, Branch JM, Chow SL, Ferrer RE, Pak S, Togioka PY, White RH.

    Ann Pharmacother. 2005 Jul-Aug;39(7-8):1182-7. Epub 2005 Jun 14.PMID: 15956232 [PubMed - indexed for MEDLINE]Related articles

    29.

    Transitioning from traditional to novel anticoagulants: the impact of oral direct thrombin inhibitors on anticoagulation management.

    Nutescu EA, Spinler SA, Dager WE, Bussey HI.

    Pharmacotherapy. 2004 Oct;24(10 Pt 2):199S-202S.PMID: 15624340 [PubMed - indexed for MEDLINE]Related articles

    30.

    Effects of pentasaccharide (fondaparinux) and direct thrombin inhibitors on coagulation testing.

    Gosselin RC, King JH, Janatpur KA, Dager WH, Larkin EC, Owings JT.

    Arch Pathol Lab Med. 2004 Oct;128(10):1142-5.PMID: 15387708 [PubMed - indexed for MEDLINE]Related articles

    31.

    Ximelagatran: an oral direct thrombin inhibitor.

    Dager WE, Vondracek TG, McIntosh BA, Nutescu EA.

    Ann Pharmacother. 2004 Nov;38(11):1881-97. Epub 2004 Sep 21. Review.PMID: 15383641 [PubMed - indexed for MEDLINE]Related articles

    32.

    Ximelagatran: a new antithrombotic option in atrial fibrillation.

    Dager WE.

    J Cardiovasc Pharmacol Ther. 2004 Sep;9(3):151-62. Review.PMID: 15378135 [PubMed - indexed for MEDLINE]Related articles

    33.

    Special considerations with fondaparinux therapy: heparin-induced thrombocytopenia and wound healing.

    Dager WE, Andersen J, Nutescu E.

    Pharmacotherapy. 2004 Jul;24(7 Pt 2):88S-94S. Review.PMID: 15317404 [PubMed - indexed for MEDLINE]Related articles

    34.

    Comparing direct thrombin inhibitors using aPTT, ecarin clotting times, and thrombin inhibitor management testing.

    Gosselin RC, King JH, Janatpour KA, Dager WE, Larkin EC, Owings JT.

    Ann Pharmacother. 2004 Sep;38(9):1383-8. Epub 2004 Jul 6.PMID: 15238620 [PubMed - indexed for MEDLINE]Related articles

    35.

    Argatroban therapy for antithrombin deficiency and mesenteric thrombosis: case report and review of the literature.

    Dager WE, Gosselin RC, Owings JT.

    Pharmacotherapy. 2004 May;24(5):659-63. Review.PMID: 15162900 [PubMed - indexed for MEDLINE]Related articles

    36.

    Effect of direct thrombin inhibitors, bivalirudin, lepirudin, and argatroban, on prothrombin time and INR values.

    Gosselin RC, Dager WE, King JH, Janatpour K, Mahackian K, Larkin EC, Owings JT.

    Am J Clin Pathol. 2004 Apr;121(4):593-9.PMID: 15080313 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Randomized trial of warfarin nomograms.

    White R, Dager W.

    Ann Intern Med. 2004 Mar 16;140(6):488-9; author reply 491-2. No abstract available. PMID: 15023719 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Anti-Xa stability of diluted enoxaparin for use in pediatrics.

    Dager WE, Gosselin RC, King JH, Christensen CL, Owings JT, Larkin EC.

    Ann Pharmacother. 2004 Apr;38(4):569-73. Epub 2004 Feb 24.PMID: 14982984 [PubMed - indexed for MEDLINE]Related articles

    39.

    Variability of plasma anti-Xa activities with different lots of enoxaparin.

    Gosselin RC, King JH, Janatpour KA, Dager WE, Larkin EC, Owings JT.

    Ann Pharmacother. 2004 Apr;38(4):563-8. Epub 2004 Feb 24.PMID: 14982983 [PubMed - indexed for MEDLINE]Related articles

    40.

    Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation.

    Dager WE, Gosselin RC, Yoshikawa R, Owings JT.

    Ann Pharmacother. 2004 Apr;38(4):598-601. Epub 2004 Feb 24.PMID: 14982973 [PubMed - indexed for MEDLINE]Related articles

    41.

    Warfarin initiation and monitoring with clotting factors II, VII, and X.

    Trask AS, Gosselin RC, Diaz JA, Dager WE.

    Ann Pharmacother. 2004 Feb;38(2):251-6. Epub 2003 Dec 30.PMID: 14742761 [PubMed - indexed for MEDLINE]Related articles

    42.

    Low-molecular-weight heparin-induced thrombocytopenia in a child.

    Dager WE, White RH.

    Ann Pharmacother. 2004 Feb;38(2):247-50. Epub 2003 Dec 23.PMID: 14742760 [PubMed - indexed for MEDLINE]Related articles

    43.

    Key articles and guidelines relative to treatment of patients with acute coronary syndromes.

    Dobesh PP, Brouse SD, Johnson DC, Dager WE, Bell D, Daly DE, Olin JL, Wodlinger AM.

    Pharmacotherapy. 2004 Jan;24(1):105-44.PMID: 14740792 [PubMed - indexed for MEDLINE]Related articles

    44.

    Overview of heparin-induced thrombocytopenia.

    Spinler SA, Dager W.

    Am J Health Syst Pharm. 2003 Oct 15;60 Suppl 5:S5-11. Review.PMID: 14593977 [PubMed - indexed for MEDLINE]Related articles

    45.

    Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.

    Dager WE, White RH.

    Ann Pharmacother. 2003 Sep;37(9):1232-6.PMID: 12921505 [PubMed - indexed for MEDLINE]Related articles

    46.

    Pharmacotherapy of heparin- induced thrombocytopenia.

    Dager WE, White RH.

    Expert Opin Pharmacother. 2003 Jun;4(6):919-40. Review.PMID: 12783589 [PubMed - indexed for MEDLINE]Related articles

    47.

    Initiating warfarin therapy.

    Dager WE.

    Ann Pharmacother. 2003 Jun;37(6):905-8. No abstract available. PMID: 12773083 [PubMed - indexed for MEDLINE]Related articles

    48.

    Inventory control for advanced cardiac life support medications.

    Dager WE.

    Ann Pharmacother. 2002 May;36(5):942-3. No abstract available. PMID: 12014356 [PubMed - indexed for MEDLINE]Related articles

    49.

    Phenytoin assay errors in uremia.

    Dager WE.

    Ann Pharmacother. 2002 May;36(5):939-40. No abstract available. PMID: 12014353 [PubMed - indexed for MEDLINE]Related articles

    50.

    Treatment of heparin-induced thrombocytopenia.

    Dager WE, White RH.

    Ann Pharmacother. 2002 Mar;36(3):489-503. Review.PMID: 11895064 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...